Xavier Demant
Overview
Explore the profile of Xavier Demant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Devaquet J, Coiffard B, Demant X, Parquin F, Devriese M, Sage E, et al.
Am J Transplant
. 2025 Feb;
PMID: 39978596
Lung transplant candidates who are highly sensitized against human leucocyte antigen have a lower likelihood of graft allocation and a higher risk of dying while on the waiting list. C1-esterase...
2.
Leveque M, Bermudez J, Nieves A, Daviet F, Roux A, Demant X, et al.
Respir Med Res
. 2025 Feb;
87:101158.
PMID: 39946979
Background: The ISHLT guidelines recommend early referral to a lung transplantation (LTx) center for patients with interstitial lung disease (ILD) due to the unpredictable course. To our knowledge, no study...
3.
Brugiere O, Dreyfuss D, Guilet R, Rong S, Hirschi S, Renaud-Picard B, et al.
Transplantation
. 2024 Sep;
PMID: 39294868
Background: Circulating extracellular vesicles (EVs) have shown promising results as noninvasive biomarkers for predicting disease outcomes in solid organ transplantation. Because in situ graft cell expression of the tolerogenic molecule...
4.
Brocard S, Morin M, Dos Santos Brito Silva N, Renaud-Picard B, Coiffard B, Demant X, et al.
Eur J Hum Genet
. 2024 Aug;
33(3):304-311.
PMID: 39164465
The main limitation to long-term lung transplant (LT) survival is chronic lung allograft dysfunction (CLAD), which leads to irreversible lung damage and significant mortality. Individual factors can impact CLAD, but...
5.
Riviere E, Jourde W, Gensous N, Demant X, Ribeiro E, Duffau P, et al.
Respir Res
. 2024 Mar;
25(1):124.
PMID: 38486260
Background: Infliximab is currently recommended as a third-line treatment for refractory sarcoidosis. Data in function of clinical phenotype are currently lacking. We evaluated patients' characteristics and responses to infliximab according...
6.
Tissot A, Durand E, Goronflot T, Coiffard B, Renaud-Picard B, Roux A, et al.
Respir Res
. 2024 Feb;
25(1):88.
PMID: 38336710
Background: Long-term outcomes of lung transplantation (LTx) remain hampered by chronic lung allograft dysfunction (CLAD). Matrix metalloproteinase 9 (MMP-9) is a secretory endopeptidase identified as a key mediator in fibrosis...
7.
Rousseliere A, Delbos L, Foureau A, Reynaud-Gaubert M, Roux A, Demant X, et al.
Front Immunol
. 2023 May;
14:1143875.
PMID: 37187736
Background: Human cytomegalovirus (HCMV) infection is common and often severe in lung transplant recipients (LTRs), and it is a risk factor associated with chronic lung allograft dysfunction (CLAD). The complex...
8.
Belaroussi Y, Hustache-Castaing R, Maury J, Lehot L, Rodriguez A, Demant X, et al.
Eur J Cardiothorac Surg
. 2023 Apr;
63(5).
PMID: 37099715
Objectives: A lung transplant is the final treatment option for end-stage lung disease. We evaluated the individual risk of 1-year mortality at each stage of the lung transplant process. Methods:...
9.
Pison C, Tissot A, Bernasconi E, Royer P, Roux A, Koutsokera A, et al.
Front Med (Lausanne)
. 2023 Mar;
10:1126697.
PMID: 36968829
Background: Chronic lung allograft dysfunction (CLAD) is the leading cause of poor long-term survival after lung transplantation (LT). Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) aimed to predict CLAD....
10.
Dauriat G, Beaumont L, Luong Nguyen L, Renaud Picard B, Penhouet M, Coiffard B, et al.
Eur Respir J
. 2022 Oct;
61(1).
PMID: 36265877
Question Addressed By The Study: Do three coronavirus disease 2019 (COVID-19) vaccine doses induce a serological response in lung transplant recipients? Methods: We retrospectively included 1071 adults (551 (52%) males)...